High Throughput Screening (HTS) Market Analysis North America,Europe,Asia,Rest of World (ROW) - US,Japan,China,Germany,France - Size and Forecast 2024-2028
| Published: Oct 2023 | Pages: 171 | SKU: IRTNTR44564 |
High Throughput Screening (HTS) Market Forecast 2024-2028
The high throughput screening market size is estimated to grow by USD 19.9 billion at a CAGR (Compound Annual Growth Rate) of 12.12% between 2023 and 2028. The increasing prevalence of chronic diseases is driving the market, facilitating drug discovery through high-throughput methods such as target screening and compound profiling. Automation expedites screening protocols and assay platforms, aiding in laboratory robotics applications. This meets the demand for new drug molecules, particularly in pharmaceutical industry contexts.
A primary trend is the focus on promotional activities, addressing challenges in product visibility. Market players promote high-throughput assays through awareness programs, supporting market expansion.
High-throughput Screening (HTS) Market Share
For More HighligHTS About this Report, Download Free Sample in a Minute
Market Segmentations
The application segment includes target identification and validation, primary and secondary screening, toxicology assessment, and stem cell research. The end-user segment includes pharmaceutical and biotechnology companies, academic and research institutes, and CROs. The geography segment includes key regions such as North America, Europe, Asia, and Rest of World (ROW).
Application Segment
The market share growth by the target identification and validation segment will be significant during the forecast period. Target identification and validation is the primary stage of drug development. Moreover, factors such as a growing pipeline for biological candidates continued outsourcing from pharmaceutical companies, and increasing demand for accurate analytical details on drugs and process development by regulatory agencies are anticipated to drive the growth of the target identification and validation segment.
Get a glance at the market research and growth contribution of various segments Download the PDF Sample
The target identification and validation segment was valued at USD 7.04 billion in 2018. The advancements made in the target identification and validation of novel drug targets using different approaches, such as advanced bioinformatics tools and automated experimental designs, and the penetration of AI and ML algorithms will further enhance the growth of the segment. Therefore, all such factors are expected to foster the growth of the target identification and validation segment in the market during the forecast period.
Regional Analysis
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 40% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
North America is the largest revenue contributor in the market due to the presence of key vendors, such as Bio-Rad Laboratories and Thermo Fisher Scientific in the region, that continually support a large number of pharmaceutical and biotechnology companies in the region through diversified portfolio offerings.
The forecast period indicates that the US and Canada will be the top revenue contributors in the region. This is due to their stable economies, robust infrastructure supporting drug launches, and substantial investments in research and development for new drugs. Personalized medicine in the US, based on patient physiologies, is transforming healthcare while increasing awareness of regenerative medicine is driving the adoption of technology. The US and Canada, being key countries in North America, are witnessing growing support for disease-related research from the biotechnology and pharmaceutical sectors.
Market Dynamics and Customer Landscape
The market is primarily driven by the increasing prevalence of chronic diseases within the Pharmaceutical and Biotechnology industries. Laboratory automation plays a pivotal role in HTS, allowing for rapid screening of large Compound Libraries using Screening assays, Biochemical assays, and Cell-based assays.
Trends in the market include advancements in High-throughput sequencing technologies, facilitating Target identification and Hit identification. Lead optimization techniques have also improved, leading to more efficient Assay development and Drug screening processes.
Challenges in the HTS market include the need for continuous innovation to enhance screening efficiency and accuracy. Additionally, managing large datasets generated from HTS assays poses challenges in data analysis and interpretation.
Overall, the HTS market continues to grow rapidly, driven by the demand for more efficient and cost-effective drug discovery solutions, and fueled by advancements in laboratory automation and screening technologies.
Key Market Driver
The increasing prevalence of chronic diseases is the key factor driving market growth. They are used for screening small molecules in the drug-finding approach, which allows different identification of candidates for the treatment of chronic conditions such as cancer, HIV, and cardiovascular diseases. The prevalence of these conditions is increasing across the globe, which is triggering the demand for products. The drug discovery process leverages automation to rapidly assess the biological or biochemical activity of a large number of drug-like compounds.
Moreover, it's useful in discovering ligands for receptors, enzymes, ion channels, or other pharmacological targets. Therefore, it is an asset to the drug discovery process, providing valuable insights and helping save time and money, which are expected to drive the high-throughput screening market. Thus, the high incidence of cancer is increasing the demand for new drug molecule screening, which is expected to drive the growth of the global market during the forecast period.
Significant Market Trends
Increasing focus on promotional activities is the primary trend shaping market growth. The nature of the product and the end user segment makes it difficult for sellers to promote their products. Unlike other products, brand and product visibility play a limited role in selling. Advertising and marketing of these products is limited and HTS is very little known. However, key high-throughput screening market players have recognized this issue. Hence, they are promoting the use through their websites.
Furthermore, as advanced products are being developed, high-throughput screening market players are beginning to realize the importance of promotional activities and awareness programs, which are likely to support the growth of the market during the forecast period. Thus, such factors are expected to drive the growth of the market during the forecast period.
Major Market Challenge
Import duty and distribution issues in developing countries is a challenge that affects market growth. The majority of manufacturers come from the US and European countries, such as the UK and Germany. On average, these suppliers have manufacturing or sales units in 3 to 5 countries. Therefore, other countries have to import tools. Almost all the major countries in APAC have high import duties for laboratory equipment, particularly China, India, and Bangladesh. The high import duties will discourage investors from importing them and setting up research facilities in these countries.
In addition, the complexity of logistics linked to the distribution of accessories, reagents, and consumables further adds to the suffering. The availability of safe third-party logistics is gradually helping manufacturers overcome this limitation, but it continues to be a significant factor adversely affecting the demand and use in developing countries. Hence, such factors may impede the growth of the market during the forecast period.
Key Companies in Market
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Agilent Technologies Inc.: The company offers products such as the Agilent RapidFire 400 high throughput mass spectrometry system.
The research report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:
- Aurora Biomed Inc.
- Axxam Spa
- Beckman Coulter Inc.
- Bio Rad Laboratories Inc.
- Biomat Srl
- BMG LABTECH GmbH
- Charles River Laboratories International Inc.
- Corning Inc.
- Danaher Corp.
- DIANA Biotechnologies s.r.o
- HighRes Biosolutions
- JSR Life Sciences LLC
- Lonza Group Ltd.
- Merck KGaA
- NanoTemper Technologies GmbH
- PerkinElmer Inc.
- Sygnature Discovery Ltd.
- Tecan Trading AG
- Thermo Fisher Scientific Inc.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Market Analyst Overview
The market revolutionizes biomedical research through cutting-edge Laboratory automation and advanced Screening assays. With vast Compound libraries and diverse Biochemical assays, researchers can efficiently screen Chemical compounds for drug discovery.
Cell-based assays and High-throughput sequencing enable rapid Pharmacological screening and Hit identification, leading to streamlined Lead optimization. High-throughput robotics and Automation systems enhance efficiency in Assay development and Drug screening.
From Screening techniques to Assay validation, the market offers robust Screening platforms and Assay optimization tools. Sample preparation and Data analysis techniques ensure accurate results using High-throughput equipment.
High-content screening and Compound screening expedite Hit validation and Lead identification, driving innovation in Bioassays and Screening efficiency. With applications in Clinical diagnostics and Biomarker discovery, high throughput screening accelerates Drug target identification and biomedical breakthroughs.
Industry trends and Technology advancements fuel market growth, offering diverse Screening applications and optimizing Assay formats. Through continuous Market analysis and report, stakeholders stay informed, fostering collaboration and innovation in biomolecular screening and laboratory techniques.
.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
171 |
|
Base year |
2023 |
|
Historic period |
2018 - 2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 12.12% |
|
Market growth 2024-2028 |
USD 19.9 billion |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
11.64 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 40% |
|
Key countries |
US, Japan, China, Germany, and France |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
Agilent Technologies Inc., Aurora Biomed Inc., Axxam Spa, Beckman Coulter Inc., Bio Rad Laboratories Inc., Biomat Srl, BMG LABTECH GmbH, Charles River Laboratories International Inc., Corning Inc., Danaher Corp., DIANA Biotechnologies s.r.o, HighRes Biosolutions, JSR Life Sciences LLC, Lonza Group Ltd., Merck KGaA, NanoTemper Technologies GmbH, PerkinElmer Inc., Sygnature Discovery Ltd., Tecan Trading AG, and Thermo Fisher Scientific Inc. |
|
Market dynamics |
Parent market analysis,Market forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
|
Customization purview |
If our market growth analysis market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
What are the Key Data Covered in this Market Research Report?
- CAGR of the market during the forecast period
- Detailed information on factors that will drive the market growth and forecasting between 2024 and 2028
- Precise estimation of the size of the market size and its contribution of the market in focus to the parent market
- Accurate predictions about upcoming market growth and trends and changes in consumer behavior
- Growth of the market industry across North America, Europe, Asia, and Rest of World (ROW)
- Thorough market trends and analysis of the market’s competitive landscape and detailed information about companies
- Comprehensive analysis of factors that will challenge the growth of market companies
We can help! Our analysts can customize this market research report to meet your requirements.
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
- Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 13: Market segments
- 3.3 Market size 2023
- 3.4 Market outlook: Forecast for 2023-2028
- Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
- 4.1 Global high throughput screening (HTS) market 2018 - 2022
- Exhibit 18: Historic Market Size – Data Table on global high throughput screening (hts) market 2018 - 2022 ($ billion)
- 4.2 Application Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size – Application Segment 2018 - 2022 ($ billion)
- 4.3 End-user Segment Analysis 2018 - 2022
- Exhibit 20: Historic Market Size – End-user Segment 2018 - 2022 ($ billion)
- 4.4 Geography Segment Analysis 2018 - 2022
- Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ billion)
- 4.5 Country Segment Analysis 2018 - 2022
- Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
- 5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
- 5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
- 5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
- 5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
- 5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
- 5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
- 5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Application
- 6.1 Market segments
- Exhibit 30: Chart on Application - Market share 2023-2028 (%)
- Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
- 6.2 Comparison by Application
- Exhibit 32: Chart on Comparison by Application
- Exhibit 33: Data Table on Comparison by Application
- 6.3 Target identification and validation - Market size and forecast 2023-2028
- Exhibit 34: Chart on Target identification and validation - Market size and forecast 2023-2028 ($ billion)
- Exhibit 35: Data Table on Target identification and validation - Market size and forecast 2023-2028 ($ billion)
- Exhibit 36: Chart on Target identification and validation - Year-over-year growth 2023-2028 (%)
- Exhibit 37: Data Table on Target identification and validation - Year-over-year growth 2023-2028 (%)
- 6.4 Primary and secondary screening - Market size and forecast 2023-2028
- Exhibit 38: Chart on Primary and secondary screening - Market size and forecast 2023-2028 ($ billion)
- Exhibit 39: Data Table on Primary and secondary screening - Market size and forecast 2023-2028 ($ billion)
- Exhibit 40: Chart on Primary and secondary screening - Year-over-year growth 2023-2028 (%)
- Exhibit 41: Data Table on Primary and secondary screening - Year-over-year growth 2023-2028 (%)
- 6.5 Toxicology assessment - Market size and forecast 2023-2028
- Exhibit 42: Chart on Toxicology assessment - Market size and forecast 2023-2028 ($ billion)
- Exhibit 43: Data Table on Toxicology assessment - Market size and forecast 2023-2028 ($ billion)
- Exhibit 44: Chart on Toxicology assessment - Year-over-year growth 2023-2028 (%)
- Exhibit 45: Data Table on Toxicology assessment - Year-over-year growth 2023-2028 (%)
- 6.6 Stem cell research - Market size and forecast 2023-2028
- Exhibit 46: Chart on Stem cell research - Market size and forecast 2023-2028 ($ billion)
- Exhibit 47: Data Table on Stem cell research - Market size and forecast 2023-2028 ($ billion)
- Exhibit 48: Chart on Stem cell research - Year-over-year growth 2023-2028 (%)
- Exhibit 49: Data Table on Stem cell research - Year-over-year growth 2023-2028 (%)
- 6.7 Market opportunity by Application
- Exhibit 50: Market opportunity by Application ($ billion)
- Exhibit 51: Data Table on Market opportunity by Application ($ billion)
7 Market Segmentation by End-user
- 7.1 Market segments
- Exhibit 52: Chart on End-user - Market share 2023-2028 (%)
- Exhibit 53: Data Table on End-user - Market share 2023-2028 (%)
- 7.2 Comparison by End-user
- Exhibit 54: Chart on Comparison by End-user
- Exhibit 55: Data Table on Comparison by End-user
- 7.3 Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028
- Exhibit 56: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ billion)
- Exhibit 57: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ billion)
- Exhibit 58: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
- Exhibit 59: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
- 7.4 Academic and research institutes - Market size and forecast 2023-2028
- Exhibit 60: Chart on Academic and research institutes - Market size and forecast 2023-2028 ($ billion)
- Exhibit 61: Data Table on Academic and research institutes - Market size and forecast 2023-2028 ($ billion)
- Exhibit 62: Chart on Academic and research institutes - Year-over-year growth 2023-2028 (%)
- Exhibit 63: Data Table on Academic and research institutes - Year-over-year growth 2023-2028 (%)
- 7.5 CROs - Market size and forecast 2023-2028
- Exhibit 64: Chart on CROs - Market size and forecast 2023-2028 ($ billion)
- Exhibit 65: Data Table on CROs - Market size and forecast 2023-2028 ($ billion)
- Exhibit 66: Chart on CROs - Year-over-year growth 2023-2028 (%)
- Exhibit 67: Data Table on CROs - Year-over-year growth 2023-2028 (%)
- 7.6 Market opportunity by End-user
- Exhibit 68: Market opportunity by End-user ($ billion)
- Exhibit 69: Data Table on Market opportunity by End-user ($ billion)
8 Customer Landscape
- 8.1 Customer landscape overview
- Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
- 9.1 Geographic segmentation
- Exhibit 71: Chart on Market share by geography 2023-2028 (%)
- Exhibit 72: Data Table on Market share by geography 2023-2028 (%)
- 9.2 Geographic comparison
- Exhibit 73: Chart on Geographic comparison
- Exhibit 74: Data Table on Geographic comparison
- 9.3 North America - Market size and forecast 2023-2028
- Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
- 9.4 Europe - Market size and forecast 2023-2028
- Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 9.5 Asia - Market size and forecast 2023-2028
- Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 9.7 US - Market size and forecast 2023-2028
- Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ billion)
- Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ billion)
- Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)
- 9.8 Germany - Market size and forecast 2023-2028
- Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
- 9.9 Japan - Market size and forecast 2023-2028
- Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
- Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
- Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
- Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
- 9.10 France - Market size and forecast 2023-2028
- Exhibit 103: Chart on France - Market size and forecast 2023-2028 ($ billion)
- Exhibit 104: Data Table on France - Market size and forecast 2023-2028 ($ billion)
- Exhibit 105: Chart on France - Year-over-year growth 2023-2028 (%)
- Exhibit 106: Data Table on France - Year-over-year growth 2023-2028 (%)
- 9.11 China - Market size and forecast 2023-2028
- Exhibit 107: Chart on China - Market size and forecast 2023-2028 ($ billion)
- Exhibit 108: Data Table on China - Market size and forecast 2023-2028 ($ billion)
- Exhibit 109: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibit 110: Data Table on China - Year-over-year growth 2023-2028 (%)
- 9.12 Market opportunity by geography
- Exhibit 111: Market opportunity by geography ($ billion)
- Exhibit 112: Data Tables on Market opportunity by geography ($ billion)
10 Drivers, Challenges, and Trends
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Exhibit 113: Impact of drivers and challenges in 2023 and 2028
- 10.4 Market trends
11 Vendor Landscape
- 11.1 Overview
- 11.2 Vendor landscape
- Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
- 11.3 Landscape disruption
- Exhibit 115: Overview on factors of disruption
- 11.4 Industry risks
- Exhibit 116: Impact of key risks on business
12 Vendor Analysis
- 12.1 Vendors covered
- Exhibit 117: Vendors covered
- 12.2 Market positioning of vendors
- Exhibit 118: Matrix on vendor position and classification
- 12.3 Agilent Technologies Inc.
- Exhibit 119: Agilent Technologies Inc. - Overview
- Exhibit 120: Agilent Technologies Inc. - Business segments
- Exhibit 121: Agilent Technologies Inc. - Key offerings
- Exhibit 122: Agilent Technologies Inc. - Segment focus
- 12.4 Aurora Biomed Inc.
- Exhibit 123: Aurora Biomed Inc. - Overview
- Exhibit 124: Aurora Biomed Inc. - Product / Service
- Exhibit 125: Aurora Biomed Inc. - Key offerings
- 12.5 Axxam Spa
- Exhibit 126: Axxam Spa - Overview
- Exhibit 127: Axxam Spa - Product / Service
- Exhibit 128: Axxam Spa - Key offerings
- 12.6 Beckman Coulter Inc.
- Exhibit 129: Beckman Coulter Inc. - Overview
- Exhibit 130: Beckman Coulter Inc. - Product / Service
- Exhibit 131: Beckman Coulter Inc. - Key offerings
- 12.7 Bio Rad Laboratories Inc.
- Exhibit 132: Bio Rad Laboratories Inc. - Overview
- Exhibit 133: Bio Rad Laboratories Inc. - Business segments
- Exhibit 134: Bio Rad Laboratories Inc. - Key news
- Exhibit 135: Bio Rad Laboratories Inc. - Key offerings
- Exhibit 136: Bio Rad Laboratories Inc. - Segment focus
- 12.8 Charles River Laboratories International Inc.
- Exhibit 137: Charles River Laboratories International Inc. - Overview
- Exhibit 138: Charles River Laboratories International Inc. - Business segments
- Exhibit 139: Charles River Laboratories International Inc. - Key news
- Exhibit 140: Charles River Laboratories International Inc. - Key offerings
- Exhibit 141: Charles River Laboratories International Inc. - Segment focus
- 12.9 Corning Inc.
- Exhibit 142: Corning Inc. - Overview
- Exhibit 143: Corning Inc. - Business segments
- Exhibit 144: Corning Inc. - Key news
- Exhibit 145: Corning Inc. - Key offerings
- Exhibit 146: Corning Inc. - Segment focus
- 12.10 Danaher Corp.
- Exhibit 147: Danaher Corp. - Overview
- Exhibit 148: Danaher Corp. - Business segments
- Exhibit 149: Danaher Corp. - Key news
- Exhibit 150: Danaher Corp. - Key offerings
- Exhibit 151: Danaher Corp. - Segment focus
- 12.11 Lonza Group Ltd.
- Exhibit 152: Lonza Group Ltd. - Overview
- Exhibit 153: Lonza Group Ltd. - Business segments
- Exhibit 154: Lonza Group Ltd. - Key news
- Exhibit 155: Lonza Group Ltd. - Key offerings
- Exhibit 156: Lonza Group Ltd. - Segment focus
- 12.12 Merck KGaA
- Exhibit 157: Merck KGaA - Overview
- Exhibit 158: Merck KGaA - Business segments
- Exhibit 159: Merck KGaA - Key news
- Exhibit 160: Merck KGaA - Key offerings
- Exhibit 161: Merck KGaA - Segment focus
- 12.13 NanoTemper Technologies GmbH
- Exhibit 162: NanoTemper Technologies GmbH - Overview
- Exhibit 163: NanoTemper Technologies GmbH - Product / Service
- Exhibit 164: NanoTemper Technologies GmbH - Key offerings
- 12.14 PerkinElmer Inc.
- Exhibit 165: PerkinElmer Inc. - Overview
- Exhibit 166: PerkinElmer Inc. - Business segments
- Exhibit 167: PerkinElmer Inc. - Key news
- Exhibit 168: PerkinElmer Inc. - Key offerings
- Exhibit 169: PerkinElmer Inc. - Segment focus
- 12.15 Sygnature Discovery Ltd.
- Exhibit 170: Sygnature Discovery Ltd. - Overview
- Exhibit 171: Sygnature Discovery Ltd. - Product / Service
- Exhibit 172: Sygnature Discovery Ltd. - Key offerings
- 12.16 Tecan Trading AG
- Exhibit 173: Tecan Trading AG - Overview
- Exhibit 174: Tecan Trading AG - Business segments
- Exhibit 175: Tecan Trading AG - Key offerings
- Exhibit 176: Tecan Trading AG - Segment focus
- 12.17 Thermo Fisher Scientific Inc.
- Exhibit 177: Thermo Fisher Scientific Inc. - Overview
- Exhibit 178: Thermo Fisher Scientific Inc. - Business segments
- Exhibit 179: Thermo Fisher Scientific Inc. - Key news
- Exhibit 180: Thermo Fisher Scientific Inc. - Key offerings
- Exhibit 181: Thermo Fisher Scientific Inc. - Segment focus
13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Exhibit 182: Inclusions checklist
- Exhibit 183: Exclusions checklist
- 13.3 Currency conversion rates for US$
- Exhibit 184: Currency conversion rates for US$
- 13.4 Research methodology
- Exhibit 185: Research methodology
- Exhibit 186: Validation techniques employed for market sizing
- Exhibit 187: Information sources
- 13.5 List of abbreviations
- Exhibit 188: List of abbreviations
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases
DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts
REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
PURCHASE FULL REPORT OF
high throughput screening (hts) market market
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
- Off-the-shelf research reports
- Reports can be tailored to meet the customer's needs
- Trusted by more than 100 fortune 500 organizations
- Information about the market's key drivers, trends, and challenges
- Parent market analysis
- Every week, 50,000 people visit our subscription platform
- Detailed vendors report with competitive landscape
- Covid-19 impact and recovery analysis
- Data on revenue-generating market segments
- Details on the market shares of various regions
- Five-force market analysis